Cross talk between PML and p53 during poliovirus infection: Implications for antiviral defense

Journal of Virology

Volumn 80, Issue 17, 2006, Pages 8582-8592

  Pampin, Mathieu ^a   Simonin, Yannick ^b   Blondel, Bruno ^b   Percherancier, Yann ^a   Chelbi Alix, Mounira K ^a  

^a CNRS   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEASOME INHIBITOR; PROTEIN MDM2; PROTEIN P53; SMALL INTERFERING RNA; UO 126;

ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; ASTROCYTOMA CELL; CELL NUCLEUS INCLUSION BODY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA BINDING; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; OSTEOSARCOMA CELL; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION; VIRUS REPLICATION; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; CELL NUCLEUS STRUCTURES; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; ORGANELLES; PHOSPHORYLATION; POLIOVIRUS; RNA, SMALL INTERFERING; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; VIRUS REPLICATION;

POLIOVIRUS;

EID: 33748636239     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00031-06     Document Type: Article

References (47)

1. Barber, G. N. 2001. Host defense, viruses and apoptosis. Cell Death Differ. 8:113-126.
2. Bernardi, R., and P. P. Pandolfi. 2003. Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 22:9048-9057.
3. Bodian, D. 1955. Emerging concept of poliomyelitis infection. Science 122: 105-108.
4. Bonilla, W. V., D. D. Pinschewer, P. klenerman, V. Rousson, M. Gaboli, P. Pandolfi, R. M. Zinkernagel, M. S. Salvato, and H. Hengartner. 2002. Effects of promyelocytic leukemia protein on virus-host balance. J. Virol. 76:3810-3818.
5. Buenz, E. J., and C. L. Howe. 2005. Picornaviruses and cell death. Trends Microbiol.
6. Carbone, R., M. Pearson, S. Minucci, and P. G. Pelicci. 2002. PML NBs associate with the hMrell complex and p53 at sites of irradiation induced DNA damage. Oncogene 21:1633-1640.
7. Chelbi-Alix, M. K., and H. de The. 1999. Herpes virus induces proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100. Oncogene 18:935-941.
8. Chelbi-Alix, M. K., L. Pelicano, F. Quignon, M. H. M. Koken, L. Venturini, M. Stadler, J. Pavlovic, L. Degos, and H. de Thé. 1995. Induction of the PML protein by interferons in normal and APL cells. Leukemia 9:2027-2033.
9. Chelbi-Alix, M. K., F. Quignon, L. Pelicano, M. H. M. Koken, and H. de The. 1998. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol. 72:1043-1051.
10. Couderc, T., C. Christodoulou, H. Kopecka, S. Marsden, L. F. Taffs, R. Crainic, and F. Horaud. 1989. Molecular pathogenesis of neural lesions induced by poliovirus type 1. J. Gen. Virol. 70:2907-2918.
11. Everett, R. D. 2001. DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20:7266-7273.
12. Ferbeyre, G., E. de Stanchina, E. Querido, N. Baptiste, C. Prives, and S. W. Lowe. 2000. PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14:2015-2027.
13. Fogal, V., M. Gostissa, P. Sandy, P. Zacchi, T. Sternsdorf, K. Jensen, P. P. Pandolfi, H. Will, C. Schneider, and G. Del Sal. 2000. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19:6185-6195.
14. Girard, S., T. Couderc, J. Destombes, D. Thiesson, F. Delpeyroux, and B. Blondel. 1999. Poliovirus induces apoptosis in the mouse central nervous system. J. Virol. 73:6066-6072.
15. Gostissa, M., T. G. Hofmann, H. Will, and G. Del Sal. 2003. Regulation of p53 functions: let's meet at the nuclear bodies. Curr. Opin. Cell Biol. 15: 351-357.
16. Hayakawa, F., and M. L. Privalsky. 2004. Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis. Cancer Cell 5:389-401.
17. He, D. C., J. A. Nickerson, and S. Penman. 1990. Core filaments of the nuclear matrix. J. Cell Biol. 110:569-580.
18. Herzer, K., S. Weyer, P. H. Krammer, P. R. Galle, and T. G. Hofmann. 2005. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells. Cancer Res. 65:10830-10837.
19. Hofmann, T. G., and H. Will. 2003. Body language: the function of PML nuclear bodies in apoptosis regulation. Cell Death Differ. 10:1290-1299.
20. Ishov, A., A. Sotnikov, D. Negorev, O. Vladimirova, N. Neff, T. Kamitani, E. Yeh, J. Strauss III, and G. Maul. 1999. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147:221-223.
21. Jensen, K., C. Shiels, and P. S. Freemont. 2001. PML protein isoforms and the RBCC/TRIM motif. Oncogene 20:7223-7233.
22. Kakunaga, S., W. Ikeda, T. Shingai, T. Fujito, A. Yamada, Y. Minami, T. Imai, and Y. Takai. 2004. Enhancement of serum- and platelet-derived growth factor-induced cell proliferation by Necl-5/Tage4/poliovirus receptor/CD 155 through the Ras-Raf-MEK-ERK signaling. J. Biol. Chem. 279:36419-36425.
23. Lallemand-Breitenbach, V., J. Zhu, F. Puvion, M. Koken, N. Honore, A. Doubeikovsky, E. Duprez, P. P. Pandolfi, E. Puvion, P. Freemont, and H. de The. 2001. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, US proteasomc recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 193:1361-1371.
24. Melnick, J. L., H. A. Wenner, and C. A. Phillips. 1979. Enteroviruses, p. 471-534. In E. H. Lennette and N. J. Schmidt (ed.), Diagnostic procedures for viral, rickettsial, and chlamydial infections, 5th ed. American Public Health Assoc., Washington, D.C.
25. Muller, S., and A. Dejean. 1999. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J. Virol. 73:5137-5143.
26. Muller, S., M. J. Matunis, and A. Dejean. 1998. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17:61-70.
27. Muller, S., W. H. Miller, and A. Dejean. 1998. Trivalent antimonials induce degradation of the PML-RAR oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells. Blood 92:4308-4316.
28. Negorev, D., and G. G. Maul. 2001. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 20:7234-7242.
29. Neznanov, N., K. M. Chumakov, L. Neznanova, A. Almasan, A. K. Banerjee, and A. V. Gudkov. 2005. Proteolytic cleavage of the p65-RelA subunit of NF-κB during poliovirus infection. J. Biol. Chem. 280:24153-24158.
30. Pearson, M., R. Carbone, C. Sebastiani, M. Cioce, M. Fagioli, S. Saito, Y. Higashimoto, E. Appella, S. Minucci, P. P. Pandolfi, and P. G. Pelicci. 2000. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406:207-210.
31. Pearson, M., and P. G. Pelicci. 2001. PML interaction with p53 and its role in apoptosis and replicative senescence. Oncogene 20:7250-7256.
32. Porta, C., R. Hadj-Slimane, M. Nejmeddine, M. Pampin, M. G. Tovey, L. Espert, S. Alvarez, and M. K. Chelbi-Alix. 2005. Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively. Oncogene 24:605-615.
33. Regad, T., and M. K. Chelbi-Alix. 2001. Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20:7274-7286.
34. Regad, T., A. Saib, V. Lallemand-Breitenbach, P. P. Pondolfi, H. de The, and M. K. Chelbi-Alix. 2001. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO. J. 20:3495-3505.
35. Rolley, N., S. Butcher, and J. Milner. 1995. Specific DNA binding by different classes of human p53 mutants. Oncogene 11:763-770.
36. Romanova, L. I., G. A. Belov, P. V. Lidsky, E. A. Tolskaya, M. S. Kolesnikova, A. G. Evstafieva, A. B. Vartapetian, D. Egger, K. Bienz, and V. I. Agol. 2005. Variability in apoptotic response to poliovirus infection. Virology 331:292-306.
37. Salomoni, P., and P. P. Pandolfi. 2002. The role of PML in tumor suppression. Cell 108:165-170.
38. Seeler, J. S., and A. Dejean. 2001. SUMO: of branched proteins and nuclear bodies. Oncogene 20:7243-7249.
39. Sharma, R., S. Raychaudhuri, and A. Dasgupta. 2004. Nuclear entry of poliovirus protease-polymerase precursor 3CD: implications for host cell transcription shut-off. Virology 320:195-205.
40. Stadler, M., M. K. Chelbi-Alix, M. H. M. Koken, L. Venturing C. Lee, A. Saïb, F. Quignon, L. Pelicano, M.-C. Guillemin, C. Schindler, and H. de Thé. 1995. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11:2565-2573.
41. Sternsdorf, T., K. Jensen, and H. Will. 1997. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 139:1621-1634.
42. Takahashi, Y., V. Lallemand-Breitenbach, J. Zhu, and H. de The. 2004. PML nuclear bodies and apoptosis. Oncogene 23:2819-2824.
43. Takaoka, A., S. Hayakawa, H. Yanai, D. Stoiber, H. Negishi, H. Kikuchi, S. Sasaki, K. Imai, T. Shibue, K. Honda, and T. Taniguchi. 2003. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 424:516-523.
44. Wang, Z.-G., D. Ruggero, S. Ronchetti, S. Zhong, M. Gaboli, R. Rivi, and P. P. Pandolfi. 1998. PML is essential for multiple apoptotic pathways. Nat. Genet. 20:266-272.
45. Weidman, M. K., P. Yalamanchili, B. Ng, W. Tsai, and A. Dasgupta. 2001. Poliovirus 3C protease-mediated degradation of transcriptional activator p53 requires a cellular activity. Virology 291:260-271.
46. Whitton, J. L., C. T. Cornell, and R. Feuer. 2005. Host and virus determinants of picornavirus pathogenesis and tropism. Nat. Rev. Microbiol. 3:765-776.
47. Zhu, J., M. H. Koken, F. Quignon, M. K. Chelbi-Alix, L. Degos, Z. Y. Wang, Z. Chen, and H. de The. 1997. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 94:3978-3983.